Answers are grounded in this paper and cite their sources.
Recent trials employing patient selection based on hypoxia biomarkers have investigated the effects of dose (distribution) modifications, and drug-induced tumor reoxygenation or radiosensitization. Encouraging results from some approaches have laid the foundation for larger follow-up studies that have the potential to change clinical practice. These clinical trials set an important precedent for future trial design and help guide the path for the future of hypoxia-directed radiotherapy.
No takes yet. Share an insight, caveat, or question.
Michael Milosevic (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: